Eivind Westrum Aabel
- Resident cardiologist and Senior researcher; MD, PhD
Eivind Westrum Aabel successfully defended his PhD thesis "Prediction of arrhythmic risk in patients with mitral annular disjunction" in May 2023. His supervisors were Professor Kristina Hermann Haugaa, MD, PhD, and Dr. Øyvind Haugen Lie, MD, PhD. In his doctoral thesis, Dr. Eivind Westrum Aabel and colleagues assessed the incidence and explored possible risk markers of ventricular arrhythmias in patients with mitral annular disjunction. The three studies of the thesis described the incidence rate of ventricular arrhythmias and described possible predictors of increased arrhythmic risk in patients with mitral annular disjunction. These observations improved our knowledge of risk stratification and provided clinicians caring for patients with mitral annular disjunction valuable information when evaluating the need for different follow-up strategies.
During his fellowship, Dr. Aabel was awarded with "Best Poster Prize" at the Annual Symposium on Heart Research two years in a row. He was also awarded with "Best Research Presentation" at the Norweigan Society of Cardiology Autumn meeting in 2021.
His research has mostly involved ventricular arrhythmias, with a focus on arrhythmic mitral valve prolapse and mitral annular disjunction, but also non-ischemic cardiomyopathy. He is the principal investigator of the first clinical trial on patients with arrhythmic mitral valve prolapse (FLECAPRO), investigating the effect of flecainide and metoprolol to suppress ventricular tachyarrhythmias.
The added value of abnormal regional myocardial function for risk prediction in arrhythmogenic right ventricular cardiomyopathy
Eur Heart J Cardiovasc Imaging (in press)
Monitoring of Myocardial Involvement in Early Arrhythmogenic Right Ventricular Cardiomyopathy Across the Age Spectrum
J Am Coll Cardiol, 82 (9), 785-797
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study
Europace, 25 (2), 634-642
Ventricular arrhythmias in arrhythmic mitral valve syndrome-a prospective continuous long-term cardiac monitoring study
Europace, 25 (2), 506-516
Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse
Europace, 24 (7), 1156-1163
Mitral Annular Disjunction: Normal or Abnormal: It Is All About Location
JACC Cardiovasc Imaging, 15 (11), 1867-1869
Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-External validation of the LMNA-risk ventricular tachyarrhythmia calculator
Heart Rhythm, 20 (3), 423-429
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
Eur Heart J, 43 (45), 4694-4703
Flecainide in patients with arrhythmic mitral valve syndrome: A case series
Heart Rhythm, 20 (4), 635-636
Cardiac Arrest in a Patient With Arrhythmic Mitral Valve Prolapse Syndrome: Multiple Possible Etiologies
JACC Case Rep, 3 (16), 1769-1773
Mitral Annulus Disjunction: Arrhythmic But Not Deadly?
JACC Cardiovasc Imaging, 14 (11), 2088-2090
Tricuspid Annulus Disjunction: Novel Findings by Cardiac Magnetic Resonance in Patients With Mitral Annulus Disjunction
JACC Cardiovasc Imaging, 14 (8), 1535-1543
The Authors' Reply
JACC Cardiovasc Imaging, 14 (8), 1684-1685